Fact CheckerSign in

NCT07199127Recruiting

Duodenal Polyposis Classification in FAP

Novel Endoscopic Classification for Duodenal Polyposis in Individuals With Familial Adenomatous Polyposis

Source: ClinicalTrials.gov · Last updated 30 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Duodenal cancer is the leading cause of cancer-related mortality in patients with familial adenomatous polyposis (FAP), yet the current Spigelman staging system provides limited predictive accuracy for advanced neoplasia. The DRACO study (Duodenal Risk Assessment in adenomatous polyposis Coli -Oncogene) is a multicenter, STROBE- and CONSORT-compliant cohort study that analyzes upper endoscopies from genetically confirmed FAP patients across independent cohorts to develop, validate, and externally test two multivariable risk models.

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
22 Sept 2025
Start date
Feb 2018
Primary completion date
Aug 2025
Lead sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
NCT number
NCT07199127

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From Feb 2018 to the primary completion date, Aug 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Duodenal surgery before study baseline endoscopy

Other

  • Histological grading of duodenal polyps incomplete
  • Follow-up data were unavailable

Who the study is looking for

  • Confirmed germline diagnosis of FAP, as defined by genetic testing
  • Two or more upper gastrointestinal endoscopies
  • Complete documentation of all Spigelman classification variables at each endoscopic evaluation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fondazione IRCCS - Istituto Nazionale dei Tumori
Coordinator of this site? Confirm its status
MilanItalyRecruiting
IRCCS Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.